Revamedical
1 known investors
Find your way into Revamedical
REVA Medical develops bioresorbable polymers for medical implants, with a focus on vascular applications. The company creates drug-eluting bioresorbable scaffolds for treating coronary artery disease, positioned as an alternative to permanent metallic stents.
Founders & leadership
BS
Bob StockmaninFounder
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Revamedical do?
- REVA Medical develops bioresorbable polymers for medical implants, with a focus on vascular applications. The company creates drug-eluting bioresorbable scaffolds for treating coronary artery disease, positioned as an alternative to permanent metallic stents.
- Who are Revamedical's investors?
- Revamedical's investors include Corewell Health Ventures.